Albany Molecular Research Inc. has signed a collaboration agreement with Multispan to co-market their G protein-coupled receptor (GPCR) drug discovery services to global pharma and biopharma clients. As part of the three-year agreement, AMRI gains access to Multispan’s differentiated GPCR cell lines, assay capabilities and expertise. Multispan will offer customers AMRI’s global integrated drug discovery services, including high-throughput screening (HTS) and discovery medicinal chemi...